George Golumbeski

George Golumbeski

Presidente en SHATTUCK LABS, INC. .

Fortuna: 303 648 $ al 31/10/2026

68 años
Health Technology
Commercial Services
Finance

Perfil

George S.
Golumbeski
is currently Chairman at Carrick Therapeutics UK Ltd., Verseau Therapeutics, Inc., Actio Biosciences, Inc., National Audubon Society, Inc., Carrick Therapeutics, Inc., and Acumen Pharmaceuticals, Inc. He serves as Independent Chairman at Shattuck Labs, Inc., Non-Executive Director at Faron Pharmaceuticals Oy, and Director at Corbus Pharmaceuticals, Inc., BlackThorn Therapeutics, Inc., Tusk Therapeutics Ltd., and Peptone Ltd. He is a Trustee at Keck Graduate Institute of Applied Life Sciences, Partner at Droia Ventures, and Venture Advisor at Vertex Ventures HC.
Former roles include Chief Executive Officer at Nabriva Therapeutics GmbH, Chairman at Aura Biosciences, Inc., BioSight Ltd., and Ananke Therapeutics, Inc., Deputy Chairman-Supervisory Board at MorphoSys AG, Independent Director at SAGE Therapeutics, Inc., Independent Director at Acceleron Pharma, Inc., Independent Director at Enanta Pharmaceuticals, Inc., President & Director at GRAIL, Inc., Director at Corbus Pharmaceuticals Holdings, Inc., Director-Business Development at Pierce Biotechnology, Inc., Vice President & Director-Corporate Development at Schwarz Pharma, Inc., Senior Director-Licensing at EMD Pharmaceuticals, Inc., Vice President-Business Development at Elan Pharmaceuticals LLC, VP-Business Development, Licensing & Strategy at Novartis Oncology, Inc., Executive Vice President-Innovation at Celgene Corp., Manager-Technology Acquisition at Promega Corp., and Independent Director at Mural Oncology Plc.
Education includes a doctorate from the University of Wisconsin conferred in 1985 and an undergraduate degree from the University of Virginia conferred in 1979.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
29/05/2026 54.613 ( 0,05 % ) 303 648 $ 31/10/2026
03/06/2026 0 ( -.--% ) - $ 31/10/2026

Cargos activos de George Golumbeski

EmpresasCargoInicio
SHATTUCK LABS, INC. Presidente 22/10/2021
ACUMEN PHARMACEUTICALS, INC. Presidente 06/11/2025
FARON PHARMACEUTICALS OY Director/Miembro de la Junta 05/05/2026
Presidente 28/09/2024
Presidente 11/10/2018
Presidente 20/10/2019
Presidente -
Presidente -
Director/Miembro de la Junta 01/01/2013
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ -

Antiguos cargos conocidos de George Golumbeski.

EmpresasCargoFin
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de George Golumbeski.

Formación de George Golumbeski.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

79

Relaciones de 1er grado

39

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas39

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

  1. Bolsa de valores
  2. Insiders
  3. George Golumbeski